Health Canada drug identification number

DIN 02248077 — PEGASYS 180 MCG

PEGASYS is a solution of Peginterferon alfa-2a marketed by PHARMAAND GMBH. The full Peginterferon alfa-2a monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02248077
Brand name
PEGASYS
Active ingredient
Peginterferon alfa-2a
Strength
180 MCG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
PHARMAAND GMBH
Health Canada status
MARKETED
Drug class
Biological response modifier (pegylated recombinant alpha interferon)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.